Mr Raymond Spencer was born in Adelaide and studied at the University of Adelaide.
Raymond has extensive business experience derived from living and working in the USA, India and Europe and brings more than thirty-five years of leadership in international business, management planning, technology, finance, organisational culture and mergers and acquisitions.
Raymond was appointed to the SAHMRI Board as Chairman on 21 December 2009. He is also Chairman of The Global Centre for Modern Ageing (GCMA) and Chairman or board member of a number of private and public companies in Australia and the U.S.A. He is an investor in and director of a number of private companies and is a member of the investment committee in three US-based venture funds.
Highly experienced in directing international projects, Raymond has worked in eighteen countries including the United States, Australia, India, UK, Hong Kong, Japan, and Singapore. He has also advised corporations and not-for-profit groups on organisational, cultural, and leadership initiatives.
Mr Young was co-author of the Shine Young Report, a review of health and medical research in South Australia commissioned by the South Australian Government which led to the Establishment of SAHMRI. Mr Young is Co-Founder and Joint Managing Director of Baker Young Stockbrokers Limited. He is also the past Founder/Chair of Belvidere Winery, Chair of the Australian Central School of Art, Vice Chair of Solstice Media Ltd, Co-Founder/Chair of Flinders Medical Centre Foundation, Founder/Chair of Flinders Bio Medical Engineering Pty Ltd, Director of NoQ Holdings USA Pty Ltd, and Director of eGrowcery Inc (USA).
In 2009 in the Queen’s Birthday Honours, Mr Young was awarded the Order of Australia for service to the community, particularly through business advisory roles within health, medical research and educational organisations including in the visual arts. In 2013 he was made a Companion of Flinders University, an award recognising his contribution to the University through his commitment to medical research and the visual arts.
Mr Young was appointed to the Board on 21 December 2009.
In October 2011 Professor Wesselingh took up the position as the inaugural Executive Director of the South Australian Health and Medical Research Institute (SAHMRI). Professor Wesselingh has also been appointed as the Infection and Immunity Theme Leader for the institute.
Professor Wesselingh was Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University, from 2007-2011. Prior to taking up the Deanship, he was Director of the Burnet Institute an independent medical research institute specialising in infectious diseases, immunology and public health.
Professor Wesselingh undertook his undergraduate and doctoral training at Flinders University/Flinders Medical Centre in South Australia and his post-doctoral training at Johns Hopkins in the United States.
Professor Wesselingh is an Infectious Diseases Physician with research interests in Neurovirology, HIV and vaccine development, more recently he has been involved in defining the role of the Microbiome in Human Health. He has consistently worked towards the integration of high quality medical research with health-care delivery, leading to improved health outcomes for Australia and the poorly resourced countries of the region.
Professor Hopwood established the Lysosomal Diseases Research Unit (LDRU) - a large multidisciplinary group researching lysosomal storage disorders nationally and internationally.
Under Professor Hopwood's stewardship, the LDRU has become world-renowned for its research capabilities in this area and the translation of research findings into state-of-the-art diagnostic services and therapeutics. The LDRU has remained at the international forefront of research into the diagnosis, treatment and biology of lysosomal diseases.
The LDRU has generated several world firsts, particularly the isolation of the genes involved in some of these disorders and the development of first-ever FDA- approved treatments for two disorders, which in 2005 and 2006 were marketed world-wide. These outcomes have led to improved quality of life for patients and multi-million dollar royalty returns to South Australia. This represents one of the largest public sector commercialisation outcomes in South Australia and possibly Australia.
Professor Hopwood has mentored 23 PhD students and 35 Post-Doctoral scientists; has over 400 peer-reviewed scientific publications, over 30 international patents and over $35 million in competitive research funding.
Robert Saint is Deputy Vice-Chancellor (Research) at Flinders University. He gained his undergraduate, honours and PhD degrees from the University of Adelaide, studying gene structure and expression in the earliest days of recombinant DNA technology.
He was a Damon Runyon Cancer Research Foundation Postdoctoral Fellow at Stanford University and NHMRC Postdoctoral Fellow at the Walter and Eliza Hall Inst. He then worked at the CSIRO before moving to the University of Adelaide in 1989, where he pioneered research into cell cycle control during animal development.
In 1994 he was appointed Professor of Genetics at the University of Adelaide and from 2000-2008 he was Director of the Australian Research Council Special Research Centre for the Molecular Genetics of Development, which began at the University of Adelaide before expanding into the ANU following Professor Saint’s move there in 2002 to take up the position of Professor of Molecular Genetics and Evolution.
In 2009 he was appointed Dean of the Faculty of Science at the University of Melbourne. He was elected a Member of the Asia-Pacific International Molecular Biology Network and has been awarded the Julian Wells Medal of the Lorne Genome Conference, the MJD White lectureship of the Genetics Society of Australia and the President’s medal of the Aust. New Zealand Society for Cell and Developmental Biology. He has been a member of the Australian Research Council College of Experts, served on NHMRC Grant Review Panels and the Human Frontier Science Program Grant Review Panel.
From 2012 to 2014 he was a standing member of the Prime Minister’s Science Engineering and Innovation Council. His research focuses on the genetic and molecular regulation of cell behaviour during animal development.
Ross Haslam was appointed as a Director to the SAHMRI Board in July, 2018. Having established himself as one of South Australia’s most highly respected accountants, and with extensive expertise in corporate responsibility, audit procedures, investment due diligence and company restructures, Ross brings a wealth of knowledge and leadership experience to SAHMRI. Additionally, with a special interest in risk management, he oversees the Audit, Finance and Risk Committee at SAHMRI.
Ross has widespread experience across the health sector and is a member of the Governing Board of the Women’s and Children’s Health Network (WCHN.
His previous positions include Chair of Flinders Medical Centre, Scotch College Adelaide and Michell Holding Pty Ltd and a Director of the Port Adelaide Football Club (AFL).
Ross gained a Bachelor of Economics (Honours) from the University of Adelaide and is a Fellow of the Chartered Accountants of Australia and New Zealand.
Jenny Richter was appointed as a Director to the SAHMRI Board in February 2018.
Jenny has over 30 years’ experience in the health sector, commencing her career as a Registered Nurse, before gaining significant leadership experience as an administrator and executive in the public and private hospital sectors, community nursing, with public private partnership projects, and within the SA public health system.
Jenny’s previous roles include Deputy Chief Executive for SA Health, a position she held for five years, and more recently as CEO of Central Adelaide Local Health Network where achievements included the development of the Clinical Trials Centre at the new RAH.
Before joining SA Health, Jenny was an Executive Director with the Plenary Group advising on health service planning and infrastructure projects. This included working with Plenary Group on the Victorian Comprehensive Cancer Centre. Jenny also has significant experience in areas of Hospital and Health service and facility planning, and health service performance both in Australia and the UK.
Jenny is a member of the Australian Institute of Company Directors, a Fellow of the Australian College of Heath Service Management and a Fellow of the Royal College of Nursing Australia. She has a Master of Business Administration, a Grad Dip in Health Administration and a Bachelor of Arts.
Professor Caroline McMillen commenced in the role as Chief Scientist for South Australia in October 2018 after serving as Vice-Chancellor of the University of Newcastle for 7 years from 2011.
She is a Fellow of the Australian Academy of Health and Medical Sciences, a Fellow of the Royal Society of New South Wales and a Bragg Member of the Royal Institution, Australia. She holds a BA (Honours) and Doctor of Philosophy from the University of Oxford, and completed her medical training graduating with an MB, BChir from the University of Cambridge. She has served in academic leadership positions at Monash University, the University of Adelaide and at the University of South Australia where she held the role of Deputy Vice-Chancellor Research and Innovation prior to her move to Newcastle.
Professor McMillen’s research focusses on the role of the environment in early development in determining the metabolic and cardiovascular health of the offspring in later life. Her research group was funded for two decades by both the ARC and the NHMRC, she was a member of the PMSEIC Working Group on Aboriginal and Torres Strait Islander health focusing on maternal, fetal and post-natal health and she has been a chair and member of international and national research policy, review and assessment panels. She has also served on a range of industry boards including the National Automotive Industry Innovation Council, Cooperative Research Centre for Advanced Automotive Technology, Cooperative Research Centre for Rail Innovation, the South Australian Premier’s Climate Change Council, the NSW Innovation and Productivity Council as well as a range of state industry and government leadership groups.
Professor McMillen has been invited to speak in international and national fora on the critical role of STEMM in driving innovation and on the role of universities as national and regional catalysts of economic and social transition. Throughout her career she has been committed to building collaborations between universities, government, industry and communities which deliver a positive impact on the economic, social and cultural health of Australia. She was honoured at the end of her term as Vice-Chancellor to be presented with the Key to the City of Newcastle by the Lord Mayor of Newcastle.
Professor Justin Beilby is an academic General Practitioner with expertise in primary care and aged care research, health service evaluation, intervention studies, and the translation of research findings into policy and clinical practice. Professor Beilby was appointed to the role of Vice-Chancellor, Torrens University Australia in January 2015. He has now transitioned to a part time role as Deputy Vice-Chancellor of Research in January 2020 where he will pursue his funded research activities. Prior to taking on his initial role at Torrens University Australia, he completed 10 years as Executive Dean of the Faculty of Health Sciences, University of Adelaide, which required oversight of all academic, educational and research programs. He also holds a Board position at the Central Adelaide Local Health Network in South Australia.
Professor Justin Beilby supervised the establishment of educational and research partnerships in the United States, India, Malyasia and Thailand. He chaired the establishment of a new global research health service partnership with academic colleagues in South America, Spain, United States and Mexico. He has previously established a number of international research relationships in the United Kingdom (respiratory and pharmaco-epidemiology) and United States.
He is practicing as a general practitioner and is currently leading an international research project examining and developing new models of managing frailty, a rising and increasingly important priority in our community.
Prior to taking on this role, he completed ten years as Executive Dean of the Faculty of Health Sciences, University of Adelaide, which required oversight of all academic, educational and research programs. He has led the academic development of the $250 million Medical and Nursing School in the South Australian Health and Biomedical Precinct and was a member of the inaugural South Australian Health and Medical Research Institute (SAHMRI) Board. In 2008 he was chosen as one of the twelve Commissioners for the National Health and Hospital Reform Commission that developed a new model for the Australian health care system.
Professor Kile commenced as Executive Dean, Faculty of Health and Medical Sciences, University of Adelaide in October 2019.
Prior to this, he was Head of the Department of Anatomy and Developmental Biology, Monash University (2017-2019), and Head of the ACRF Chemical Biology Division at the Walter & Eliza Hall Institute of Medical Research (WEHI) (2014-2017).
Ben conducted his PhD training in the Cancer and Hematology Division at WEHI, and postdoctoral research at Baylor College of Medicine in Houston, USA. He returned to WEHI in 2004 and established an independent research laboratory there in 2008.
Professor Kile is a medical researcher internationally recognised for his work in blood cell development and survival, particularly in the context of cancer chemotherapy and its impact on the hematopoietic system.
Eddie Fry is an experienced businessman who’s worked extensively in the resources sector and specialises in financial and human resource management as well as Indigenous and Native Title issues. He also brings with him a wealth of corporate governance expertise, currently sitting on a number of boards including serving as Chair of the Indigenous Land and Sea Corporation and Indigenous Business Australia. He is a Dagoman man who becomes our first Board member who identifies as Aboriginal or Torres Strait Islander.
ABN 54 141 228 346 | © SAHMRI, 2021.
SAHMRI is located on the traditional lands of the Kaurna people.
The SAHMRI community acknowledges and pays respect to the Kaurna people as the traditional custodians of the Adelaide region. We also acknowledge the deep feelings of attachment and the relationship of the Kaurna people to their country. We pay our respects to the Kaurna peoples' ancestors and the living Kaurna people today.